NeraCare develops and commercializes molecular diagnostic tests for patients with skin cancer. The tests provide actionable, tumor-specific information for each individual patient. The information is used to make improved treatment decisions, i.e. whether therapy is absolutely necessary or whether a patients' survival estimate is so favourable that it is reasonable to avoid drug therapy and the associated, severe side effects. Through its partnerships with pharmaceutical companies and leading investigators, NeraCare is at the forefront of designing cutting-edge clinical trials to help expand access to drugs for early stage patients.
| Website | http://www.neracare.com |
| Employees | 9 (3 on RocketReach) |
| Founded | 2015 |
| Industry | Medical Practices |
| Keywords | Skin Cancer Diagnostics, Molecular Diagnostics, Tumor Diagnostics, Molecular Testing, Personalized Medicine, Diagnostic Tests, Oncology Diagnostics, Precision Oncology, Dermatopathology, Molecular Pathology, Cancer Biomarkers, In Vitro Diagnostics, Patient Stratification, Therapeutic Guidance, Cancer Research, Medical Diagnostics, Clinical Diagnostics |
| Competitors | Kindred Hospitals, BAYADA Home Health Care, Amedisys, Comfort Keepers, Alacare Home Health & Hospice, Visiting Angels, BrightStar Care, Care.com, HHAeXchange, Lifespark +30 more (view full list) |
Looking for a particular NeraCare employee's phone or email?
NeraCare Questions
Michael Oed is the CTO of NeraCare.
3 people are employed at NeraCare.
Top NeraCare Employees
-
Michael Oed
Chief Technology Officer at NeraCare
Rodgau, HE, DE1 -
Daniel von Janowski
Co-Founder at NeraCare
Houston, TX, US21
Related Companies
